CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Astellas Pharma Inc. - 4503 CFD

1432.66
0.03%
Market Trading Hours* (UTC) Opens on Monday at 00:00

Mon - Fri: 00:00 - 02:30 03:30 - 06:25

  • Summary
  • Historical Data
Trading сonditions
Spread 3.68
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.012355 %
Charges from full value of position ($-2.35)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.012355%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.009867 %
Charges from full value of position ($-1.87)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.009867%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency JPY
Margin 5.00%
Stock exchange Japan
Commission on trade 0%

Key Stats
Prev. Close 1433.16
Open 1421.77
1-Year Change -12.26%
Day's Range 1421.77 - 1441.15
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 7, 2025 1432.66 9.49 0.67% 1423.17 1442.05 1421.67
Feb 6, 2025 1433.16 1.00 0.07% 1432.16 1442.75 1422.27
Feb 5, 2025 1423.87 -45.25 -3.08% 1469.12 1469.12 1411.78
Feb 4, 2025 1482.61 6.90 0.47% 1475.71 1501.49 1475.71
Feb 3, 2025 1470.62 -26.57 -1.77% 1497.19 1498.79 1466.73
Jan 31, 2025 1515.58 -6.59 -0.43% 1522.17 1524.27 1509.18
Jan 30, 2025 1528.76 2.69 0.18% 1526.07 1533.16 1515.18
Jan 29, 2025 1531.56 0.80 0.05% 1530.76 1533.66 1517.98
Jan 28, 2025 1541.95 10.39 0.68% 1531.56 1550.84 1522.77
Jan 27, 2025 1516.08 9.79 0.65% 1506.29 1525.67 1506.28
Jan 24, 2025 1503.09 7.99 0.53% 1495.10 1512.28 1489.30
Jan 23, 2025 1476.72 6.90 0.47% 1469.82 1480.41 1455.83
Jan 22, 2025 1484.11 -6.49 -0.44% 1490.60 1496.10 1479.81
Jan 21, 2025 1483.61 -1.70 -0.11% 1485.31 1494.30 1479.81
Jan 20, 2025 1482.11 -7.19 -0.48% 1489.30 1493.70 1472.32
Jan 17, 2025 1494.80 -6.49 -0.43% 1501.29 1504.69 1485.81
Jan 16, 2025 1505.59 -12.08 -0.80% 1517.67 1520.57 1502.19
Jan 15, 2025 1529.36 -5.00 -0.33% 1534.36 1556.04 1527.47
Jan 14, 2025 1519.77 14.18 0.94% 1505.59 1520.77 1498.29
Jan 10, 2025 1507.48 -25.18 -1.64% 1532.66 1532.66 1503.19

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Astellas Pharma Inc. Company profile

About Astellas Pharma Inc

Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.

Financial summary

BRIEF: For the nine months ended 31 December 2021, Astellas Pharma Inc revenues increased 5% to Y992.29B. Net income applicable to common stockholders decreased less than 1% to Y132.49B. Revenues reflect Sales of Pharmaceuticals segment increase of 6% to Y971.11B, Other Business segment increase of 33% to Y14.07B, Americas segment increase of 15% to Y407.94B, Estabridge segment increase of 10% to Y239.22B.

Equity composition

04/2005, Company merged with Fujisawa Pharmaceutical Co., Ltd. & Name Changed from Yamanouchi Pharmaceutical Co., Ltd. FY'08 1Q&Q3 WAS & DWAS estimated and WAS used as O/S. FY'09 Q3,12 Q2 DWAS estimated.

Industry: Pharmaceuticals (NEC)

日本橋本町2-5-1
CHUO-KU
TOKYO-TO 103-8411
JP

People also watch

Gold

2,860.88 Price
+0.160% 1D Chg, %
Long position overnight fee -0.0066%
Short position overnight fee -0.0017%
Overnight fee time 22:00 (UTC)
Spread 0.60

US100

21,475.70 Price
-1.210% 1D Chg, %
Long position overnight fee -0.0235%
Short position overnight fee 0.0013%
Overnight fee time 22:00 (UTC)
Spread 1.8

ETH/USD

2,668.31 Price
+1.050% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

XRP/USD

2.49 Price
+2.140% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01242

Still looking for a broker you can trust?

Join the 690,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading